7th Gene Therapy Analytical Development Summit Europe 2026
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in GBP.
Register by Friday, March 27th & Save up to £600
Drug Developer Pricing*
Conference + 2 Workshops
(Save £600)
£3,197
On the Door: £3,797
Conference + 1 Workshop
(Save £450)
£2,798
On the Door: £3,248
Conference Only
(Save £300)
£2,399
On the Door: £2,699
Academic Pricing**
Conference + 2 Workshops
(Save £600)
£2,597
On the Door: £3,197
Conference + 1 Workshop
(Save £450)
£2,298
On the Door: £2,748
Conference Only
(Save £300)
£1,999
On the Door: £2,299
Service Provider Pricing***
Conference + 2 Workshops
(Save £600)
£3,897
On the Door: £4,497
Conference + 1 Workshop
(Save £450)
£3,398
On the Door: £3,848
Conference Only
(Save £300)
£2,899
On the Door: £3,199
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when two or more delegates from one company book and pay at the same time.
10% Off
When registering 2 attendees from one company
15% Off
When registering 3 attendees from one company
20% Off
When registering 4+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help in the booking process, contact us and one of the team will get back to you.
Explore the Agenda
- 16+ expert speakers from the likes of AAVantgarde, UCB, PureSpring Therapeutics, Regeneron, and UniQure
- 3 days of cutting-edge analytical and QC content addressing the toughest challenges in potency assurance, product characterisation, and analytical readiness across gene therapy platforms
- 6 hours of immersive, case-study led sessions tackling both earlier stage analytical development and later stage QC challenges
- Regulatory-led sessions featuring voices from the Medicines and Healthcare products Regulatory Agency (MHRA) with pharmacopeial insights
